|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
123,030,000 |
Market
Cap: |
19.73(B) |
Last
Volume: |
638,793 |
Avg
Vol: |
721,790 |
52
Week Range: |
$143.31 - $211.65 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 824 |
Guru Rank Value : 0.5 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing therapeutics based on RNA interference. Co. has four RNAi-based medicines, ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO (lumasiran) and Leqvio® (inclisiran). ONPATTRO is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. GIVLAARI is approved for the treatment of adults with acute hepatic porphyria. Co. has approval for OXLUMO for the treatment of hyperoxaluria type 1 (PH1) in all age groups. Leqvio (inclisiran) is being developed for the treatment of adults with hypercholesterolemia or mixed dyslipidemia.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
21,700 |
98,555 |
124,204 |
268,793 |
Total Sell Value |
$3,224,546 |
$16,182,261 |
$20,937,886 |
$52,053,725 |
Total People Sold |
1 |
8 |
9 |
10 |
Total Sell Transactions |
1 |
13 |
19 |
36 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Maraganore John |
CEO |
|
2007-06-29 |
4 |
AS |
$15.23 |
$287,605 |
D/D |
(18,722) |
18,778 |
|
- |
|
Maraganore John |
CEO |
|
2007-06-29 |
4 |
OE |
$0.48 |
$17,813 |
D/D |
37,500 |
37,500 |
|
- |
|
Maraganore John |
CEO |
|
2007-06-28 |
4 |
AS |
$15.78 |
$320,253 |
D/D |
(20,069) |
17,431 |
|
- |
|
Maraganore John |
CEO |
|
2007-06-28 |
4 |
OE |
$0.48 |
$17,813 |
D/D |
37,500 |
37,500 |
|
- |
|
Maraganore John |
CEO |
|
2007-06-28 |
4 |
AS |
$16.05 |
$280,262 |
D/D |
(17,431) |
0 |
|
- |
|
Greene Barry E |
COO and Treasurer |
|
2006-10-31 |
4 |
AS |
$20.71 |
$258,875 |
D/D |
(12,500) |
42,051 |
|
- |
|
Maraganore John |
President & CEO |
|
2006-05-12 |
4 |
AS |
$14.94 |
$206,933 |
D/D |
(13,322) |
5,135 |
|
- |
|
Maraganore John |
President & CEO |
|
2006-05-12 |
4 |
AS |
$15.01 |
$428,070 |
D/D |
(28,313) |
18,457 |
|
- |
|
Maraganore John |
President & CEO |
|
2006-05-12 |
4 |
OE |
$0.48 |
$17,813 |
D/D |
37,500 |
46,770 |
|
- |
|
Barrett Peter |
Director |
|
2006-03-07 |
4 |
S |
$16.51 |
$359,826 |
I/I |
(21,800) |
5,293 |
|
- |
|
Barrett Peter |
Director |
|
2006-03-06 |
4 |
S |
$17.20 |
$1,086,920 |
I/I |
(63,200) |
5,522 |
|
- |
|
Barrett Peter |
Director |
|
2006-03-03 |
4 |
S |
$16.89 |
$3,018,966 |
I/I |
(178,782) |
0 |
|
- |
|
Barrett Peter |
Director |
|
2006-03-02 |
4 |
S |
$16.06 |
$994,386 |
I/I |
(61,900) |
8,065 |
|
- |
|
Barrett Peter |
Director |
|
2006-03-01 |
4 |
S |
$16.06 |
$1,207,419 |
I/I |
(75,200) |
0 |
|
- |
|
Schimmel Paul |
Director |
|
2006-02-28 |
5 |
GD |
$0.00 |
$0 |
I/I |
1,615 |
336,473 |
|
- |
|
Barrett Peter |
Director |
|
2006-02-28 |
4 |
S |
$15.98 |
$1,463,338 |
I/I |
(91,549) |
9,506 |
|
- |
|
Barrett Peter |
Director |
|
2006-02-27 |
4 |
S |
$15.77 |
$3,942,975 |
I/I |
(250,000) |
0 |
|
- |
|
Atlas Venture Associates Vi, L.p. |
10% Owner |
|
2006-02-24 |
4 |
S |
$14.80 |
$887,820 |
I/I |
(60,000) |
747,580 |
|
- |
|
Atlas Venture Associates Vi, L.p. |
10% Owner |
|
2006-02-24 |
4 |
S |
$14.80 |
$887,820 |
D/D |
(60,000) |
13,095 |
|
- |
|
Barrett Peter |
Director |
|
2006-02-24 |
4 |
S |
$14.80 |
$887,820 |
I/I |
(60,000) |
13,095 |
|
- |
|
Atlas Venture Associates Vi, L.p. |
10% Owner |
|
2006-02-23 |
4 |
S |
$15.14 |
$476,960 |
I/I |
(31,500) |
0 |
|
- |
|
Atlas Venture Associates Vi, L.p. |
10% Owner |
|
2006-02-23 |
4 |
S |
$15.14 |
$476,960 |
D/D |
(31,500) |
0 |
|
- |
|
Barrett Peter |
Director |
|
2006-02-23 |
4 |
S |
$15.14 |
$476,960 |
I/I |
(31,500) |
0 |
|
- |
|
Schimmel Paul |
officerTitle |
|
2006-01-31 |
4 |
B |
$13.00 |
$1,300,000 |
I/I |
100,000 |
338,088 |
2.1 |
- |
|
Allen Patricia L |
officerTitle |
|
2006-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,070 |
|
- |
|
748 Records found
|
|
Page 27 of 30 |
|
|